Literature DB >> 20673763

The plasma membrane redox system is impaired by amyloid β-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice.

Dong-Hoon Hyun1, Mohamed R Mughal, Hyunwon Yang, Ji Hyun Lee, Eun Joo Ko, Nicole D Hunt, Rafael de Cabo, Mark P Mattson.   

Abstract

Membrane-associated oxidative stress has been implicated in the synaptic dysfunction and neuronal degeneration that occurs in Alzheimer's disease (AD), but the underlying mechanisms are unknown. Enzymes of the plasma membrane redox system (PMRS) provide electrons for energy metabolism and recycling of antioxidants. Here, we show that activities of several PMRS enzymes are selectively decreased in plasma membranes from the hippocampus and cerebral cortex of 3xTgAD mice, an animal model of AD. Our results that indicate the decreased PMRS enzyme activities are associated with decreased levels of coenzyme Q(10) and increased levels of oxidative stress markers. Neurons overexpressing the PMRS enzymes (NQO1 or cytochrome b5 reductase) exhibit increased resistance to amyloid β-peptide (Aβ). If and to what extent Aβ is the cause of the impaired PMRS enzymes in the 3xTgAD mice is unknown. Because these mice also express mutant tau and presenilin-1, it is possible that one or more of the PMRS could be adversely affected by these mutations. Nevertheless, the results of our cell culture studies clearly show that exposure of neurons to Aβ1-42 is sufficient to impair PMRS enzymes. The impairment of the PMRS in an animal model of AD, and the ability of PMRS enzyme activities to protect neurons against Aβ-toxicity, suggest enhancement PMRS function as a novel approach for protecting neurons against oxidative damage in AD and related disorders.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673763      PMCID: PMC2946538          DOI: 10.1016/j.expneurol.2010.07.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  53 in total

1.  Redox-active iron mediates amyloid-beta toxicity.

Authors:  C A Rottkamp; A K Raina; X Zhu; E Gaier; A I Bush; C S Atwood; M Chevion; G Perry; M A Smith
Journal:  Free Radic Biol Med       Date:  2001-02-15       Impact factor: 7.376

2.  Plasma membrane redox system protects cells against oxidative stress.

Authors:  J C Rodríguez-Aguilera; G López-Lluch; C Santos-Ocaña; J M Villalba; C Gómez-Díaz; P Navas
Journal:  Redox Rep       Date:  2000       Impact factor: 4.412

Review 3.  Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions.

Authors:  T Lynch; R A Cherny; A I Bush
Journal:  Exp Gerontol       Date:  2000-07       Impact factor: 4.032

4.  beta-amyloid induces caspase-dependent early neurotoxic change in PC12 cells: correlation with H2O2 neurotoxicity.

Authors:  T Saito; H Kijima; Y Kiuchi; Y Isobe; K Fukushima
Journal:  Neurosci Lett       Date:  2001-06-01       Impact factor: 3.046

5.  Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

Authors:  D Praticò; K Uryu; S Leight; J Q Trojanoswki; V M Lee
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

Review 6.  The toxicity in vitro of beta-amyloid protein.

Authors:  L L Iversen; R J Mortishire-Smith; S J Pollack; M S Shearman
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

Review 7.  Plasma membrane redox system in the control of stress-induced apoptosis.

Authors:  J M Villalba; P Navas
Journal:  Antioxid Redox Signal       Date:  2000       Impact factor: 8.401

8.  Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease.

Authors:  A K Raina; D J Templeton; J C Deak; G Perry; M A Smith
Journal:  Redox Rep       Date:  1999       Impact factor: 4.412

9.  Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation.

Authors:  R J Mark; Z Pang; J W Geddes; K Uchida; M P Mattson
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

10.  Postmortem changes in drug-metabolizing enzymes of rat liver microsome.

Authors:  M Yamazaki; C Wakasugi
Journal:  Forensic Sci Int       Date:  1994-08-10       Impact factor: 2.395

View more
  12 in total

1.  Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice.

Authors:  Ceyhan Elipenahli; Cliona Stack; Shari Jainuddin; Meri Gerges; Lichuan Yang; Anatoly Starkov; M Flint Beal; Magali Dumont
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease.

Authors:  Simonetta Camandola; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-10-13

Review 3.  Cellular membrane fluidity in amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Grace Y Sun; Gunter P Eckert; James C-M Lee
Journal:  Mol Neurobiol       Date:  2014-02-20       Impact factor: 5.590

4.  Cytochrome b5 reductase, a plasma membrane redox enzyme, protects neuronal cells against metabolic and oxidative stress through maintaining redox state and bioenergetics.

Authors:  Dong-Hoon Hyun; Ga-Hyun Lee
Journal:  Age (Dordr)       Date:  2015-11-26

5.  Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity.

Authors:  Anne Eckert; Karen Schmitt; Jürgen Götz
Journal:  Alzheimers Res Ther       Date:  2011-05-05       Impact factor: 6.982

6.  The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease-old wine in new bottles.

Authors:  Karl H Braunewell
Journal:  Front Mol Neurosci       Date:  2012-02-23       Impact factor: 5.639

7.  DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes.

Authors:  Peter Sykora; Magdalena Misiak; Yue Wang; Somnath Ghosh; Giovana S Leandro; Dong Liu; Jane Tian; Beverly A Baptiste; Wei-Na Cong; Boris M Brenerman; Evandro Fang; Kevin G Becker; Royce J Hamilton; Soumya Chigurupati; Yongqing Zhang; Josephine M Egan; Deborah L Croteau; David M Wilson; Mark P Mattson; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2014-12-30       Impact factor: 16.971

8.  Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle.

Authors:  Mark P Mattson
Journal:  NPJ Aging Mech Dis       Date:  2015-09-28

9.  A rapid and non-invasive fluorescence method for quantifying coenzyme Q10 in blood and urine in clinical analysis.

Authors:  Xuechao Fei; Yan Yu; Yalan Di; Li Ai; Dandan Yao; Shangying Bai; Shengjie Zhao; Jihui Lyu; Xiang Cai; Rongqiao He; Zhiqian Tong
Journal:  J Clin Lab Anal       Date:  2019-12-25       Impact factor: 2.352

10.  Mitochondrial function in human neuroblastoma cells is up-regulated and protected by NQO1, a plasma membrane redox enzyme.

Authors:  Jiyeong Kim; Su-Kyung Kim; Hwa-Kyung Kim; Mark P Mattson; Dong-Hoon Hyun
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.